Literature DB >> 32102749

Antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae.

Chi-Chung Chen1, Chih-Cheng Lai2, Hui-Ling Huang3, Yu-Ting Su4, Yu-Hsin Chiu5, Han-Siong Toh6, Shyh-Ren Chiang7, Yin-Ching Chuang8, Ying-Chen Lu9, Hung-Jen Tang10.   

Abstract

BACKGROUND: This study aims to investigate the antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae (CPE).
METHODS: Five Lactobacillus spp. strains and 18 CPE clinical isolates were collected. Their anti-CPE effects were assessed by agar well diffusion and broth microdilution assay, as well as time-kill test. Finally, the specific anti-CPE mechanism, especially for the effect of organic acids was determined using broth microdilution method.
RESULTS: All of five Lactobacilli isolates displayed the potent activity against most CPE isolates with mean zones of inhibition ranging 10.2-21.1 mm. The anti-CPE activity was not affected by heating, catalase, and proteinase treatment. Under the concentration of 50% LUC0180 cell-free supernatant (CFS), lactic acid, and mix acid could totally inhibit the growth of carbapenem-resistant Klebsiella pneumoniae (CPE0011), and acetic acid could inhibit 67.8%. In contrast, succinic acid and citric acid could not inhibit the growth of CPE0011. While we decreased the concentration to 25%, only lactic acid and mix acid displayed 100% inhibition. In contrast, succinic acid, citric acid and acetic acid did not show any inhibitory effect.
CONCLUSIONS: Lactobacillus strains exhibit potent anti-CPE activity, and lactic acid produced by Lactobacillus strains is the major antimicrobial mechanism.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Carbapenemase-producing Enterobacteriaceae; In vitro activity; Lactic acid; Lactobacillus; Organic acid

Year:  2020        PMID: 32102749     DOI: 10.1016/j.jmii.2020.01.005

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  4 in total

1.  New Wild-Type Lacticaseibacillus rhamnosus Strains as Candidates to Manage Type 1 Diabetes.

Authors:  Grigorios Nelios; Valentini Santarmaki; Chrysoula Pavlatou; Dimitra Dimitrellou; Yiannis Kourkoutas
Journal:  Microorganisms       Date:  2022-01-25

2.  Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function.

Authors:  Ji Taek Hong; Min-Jung Lee; Sang Jun Yoon; Seok Pyo Shin; Chang Seok Bang; Gwang Ho Baik; Dong Joon Kim; Gi Soo Youn; Min Jea Shin; Young Lim Ham; Ki Tae Suk; Bong-Soo Kim
Journal:  J Ginseng Res       Date:  2020-07-16       Impact factor: 6.060

3.  Anticolonization of Carbapenem-Resistant Klebsiella pneumoniae by Lactobacillus plantarum LP1812 Through Accumulated Acetic Acid in Mice Intestinal.

Authors:  Rushuang Yan; Ye Lu; Xiaoqing Wu; Peihao Yu; Peng Lan; Xueqing Wu; Yan Jiang; Qi Li; Xionge Pi; Wei Liu; Jiancang Zhou; Yunsong Yu
Journal:  Front Cell Infect Microbiol       Date:  2021-12-15       Impact factor: 5.293

Review 4.  Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.

Authors:  Shio-Shin Jean; Dorji Harnod; Po-Ren Hsueh
Journal:  Front Cell Infect Microbiol       Date:  2022-03-15       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.